Sutro Biopharma (STRO) Free Cash Flow (QoQ) (2018 - 2025)
Sutro Biopharma (STRO) Free Cash Flow (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sutro Biopharma | 192.86 Mn | 51.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.91% |
| Sep 30, 2025 | 11.28% |
| Jun 30, 2025 | 34.15% |
| Mar 31, 2025 | 8.43% |
| Dec 31, 2024 | -15.89% |
| Sep 30, 2024 | -835.60% |
| Jun 30, 2024 | 113.34% |
| Mar 31, 2024 | -559.55% |
| Dec 31, 2023 | 145.34% |
| Sep 30, 2023 | 4.62% |
| Jun 30, 2023 | 47.04% |
| Mar 31, 2023 | -176.87% |
| Dec 31, 2022 | -132.98% |
| Sep 30, 2022 | 1,219.71% |
| Jun 30, 2022 | 83.24% |
| Mar 31, 2022 | -4.02% |
| Dec 31, 2021 | -37.88% |
| Sep 30, 2021 | -332.16% |
| Jun 30, 2021 | 81.34% |
| Mar 31, 2021 | -52.36% |